Return to Statistics Toolbox

Volcano Plot analysis for Study ST003412

(Analysis All analyses used)
Select one or more experimental factors for Groups 1 and 2. The members of each group should be DIFFERENT.
Group1Experimental factorGroup2
Sample source:BT-474 Breast cancer cells | Sample Type:Intracellular | Drug:cerulenin | Drug Treatment:0.5 uM cerulenin (3)
Sample source:BT-474 Breast cancer cells | Sample Type:Intracellular | Drug:cerulenin | Drug Treatment:2.0 uM cerulenin (3)
Sample source:BT-474 Breast cancer cells | Sample Type:Intracellular | Drug:cerulenin | Drug Treatment:20 uM cerulenin (3)
Sample source:BT-474 Breast cancer cells | Sample Type:Intracellular | Drug:cerulenin | Drug Treatment:4.0 uM cerulenin (3)
Sample source:BT-474 Breast cancer cells | Sample Type:Intracellular | Drug:cerulenin | Drug Treatment:50 uM cerulenin (3)
Sample source:BT-474 Breast cancer cells | Sample Type:Intracellular | Drug:cerulenin | Drug Treatment:6.0 uM cerulenin (3)
Sample source:BT-474 Breast cancer cells | Sample Type:Intracellular | Drug:NA | Drug Treatment:Control (9)
Sample source:BT-474 Breast cancer cells | Sample Type:Intracellular | Drug:TVB-2640 | Drug Treatment:1 nM TVB-2640 (3)
Sample source:BT-474 Breast cancer cells | Sample Type:Intracellular | Drug:TVB-2640 | Drug Treatment:200 nM TVB-2640 (3)
Sample source:BT-474 Breast cancer cells | Sample Type:Intracellular | Drug:TVB-2640 | Drug Treatment:20 nM TVB-2640 (3)
Sample source:BT-474 Breast cancer cells | Sample Type:Intracellular | Drug:TVB-2640 | Drug Treatment:500 nM TVB-2640 (3)
Sample source:BT-474 Breast cancer cells | Sample Type:Intracellular | Drug:TVB-2640 | Drug Treatment:50 nM TVB-2640 (3)
Sample source:BT-474 Breast cancer cells | Sample Type:Intracellular | Drug:TVB-2640 | Drug Treatment:5 uM TVB-2640 (3)
Sample source:BT-474 Breast cancer cells | Sample Type:Intracellular | Drug:TVB-3166 | Drug Treatment:1 nM TVB-3166 (3)
Sample source:BT-474 Breast cancer cells | Sample Type:Intracellular | Drug:TVB-3166 | Drug Treatment:200 nM TVB-3166 (3)
Sample source:BT-474 Breast cancer cells | Sample Type:Intracellular | Drug:TVB-3166 | Drug Treatment:20 nM TVB-3166 (3)
Sample source:BT-474 Breast cancer cells | Sample Type:Intracellular | Drug:TVB-3166 | Drug Treatment:500 nM TVB-3166 (3)
Sample source:BT-474 Breast cancer cells | Sample Type:Intracellular | Drug:TVB-3166 | Drug Treatment:50 nM TVB-3166 (3)
Sample source:BT-474 Breast cancer cells | Sample Type:Intracellular | Drug:TVB-3166 | Drug Treatment:5 uM TVB-3166 (3)
Sample source:BT-474 Breast cancer cells | Sample Type:Medium | Drug:cerulenin | Drug Treatment:0.5 uM cerulenin (3)
Sample source:BT-474 Breast cancer cells | Sample Type:Medium | Drug:cerulenin | Drug Treatment:2.0 uM cerulenin (3)
Sample source:BT-474 Breast cancer cells | Sample Type:Medium | Drug:cerulenin | Drug Treatment:20 uM cerulenin (3)
Sample source:BT-474 Breast cancer cells | Sample Type:Medium | Drug:cerulenin | Drug Treatment:4.0 uM cerulenin (3)
Sample source:BT-474 Breast cancer cells | Sample Type:Medium | Drug:cerulenin | Drug Treatment:50 uM cerulenin (3)
Sample source:BT-474 Breast cancer cells | Sample Type:Medium | Drug:cerulenin | Drug Treatment:6.0 uM cerulenin (3)
Sample source:BT-474 Breast cancer cells | Sample Type:Medium | Drug:NA | Drug Treatment:Control (9)
Sample source:BT-474 Breast cancer cells | Sample Type:Medium | Drug:TVB-2640 | Drug Treatment:1 nM TVB-2640 (3)
Sample source:BT-474 Breast cancer cells | Sample Type:Medium | Drug:TVB-2640 | Drug Treatment:200 nM TVB-2640 (3)
Sample source:BT-474 Breast cancer cells | Sample Type:Medium | Drug:TVB-2640 | Drug Treatment:20 nM TVB-2640 (3)
Sample source:BT-474 Breast cancer cells | Sample Type:Medium | Drug:TVB-2640 | Drug Treatment:500 nM TVB-2640 (3)
Sample source:BT-474 Breast cancer cells | Sample Type:Medium | Drug:TVB-2640 | Drug Treatment:50 nM TVB-2640 (3)
Sample source:BT-474 Breast cancer cells | Sample Type:Medium | Drug:TVB-2640 | Drug Treatment:5 uM TVB-2640 (3)
Sample source:BT-474 Breast cancer cells | Sample Type:Medium | Drug:TVB-3166 | Drug Treatment:1 nM TVB-3166 (3)
Sample source:BT-474 Breast cancer cells | Sample Type:Medium | Drug:TVB-3166 | Drug Treatment:200 nM TVB-3166 (3)
Sample source:BT-474 Breast cancer cells | Sample Type:Medium | Drug:TVB-3166 | Drug Treatment:20 nM TVB-3166 (3)
Sample source:BT-474 Breast cancer cells | Sample Type:Medium | Drug:TVB-3166 | Drug Treatment:500 nM TVB-3166 (3)
Sample source:BT-474 Breast cancer cells | Sample Type:Medium | Drug:TVB-3166 | Drug Treatment:50 nM TVB-3166 (3)
Sample source:BT-474 Breast cancer cells | Sample Type:Medium | Drug:TVB-3166 | Drug Treatment:5 uM TVB-3166 (3)
Sample source:NA | Sample Type:Blank | Drug:- | Drug Treatment:NA (2)
Sample source:NA | Sample Type:Blank | Drug:NA | Drug Treatment:NA (6)
Sample source:NA | Sample Type:Medium | Drug:NA | Drug Treatment:NA (9)
Sample source:NA | Sample Type:QC | Drug:- | Drug Treatment:NA (1)
Sample source:NA | Sample Type:QC | Drug:NA | Drug Treatment:NA (3)
P-value cutoff:    Fold-change cutoff:    Sample normalization:
Group by metabolite classification:    Use:
Maximum # of (most significant) metabolites per class to use in pvalue group calculation:
Analysis:Combine data for all analyses?:     

  logo